C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
12/2004
12/23/2004	US20040259877 Inhibitors against the production and release of inflammatory cytokines
12/23/2004	US20040259874 Morpholine dopamine agonists
12/23/2004	US20040259873 For treating, preventing and managing various disease or disorders such as central nervous system (CNS) disorders; myelodysplastic syndrome (MDS) and related syndromes; complex regional pain syndrome (CRPS) and related syndromes; cancer
12/23/2004	US20040259871 Carbonylbenzoxazine compounds for enhancing glutamatergic synaptic responses
12/23/2004	US20040259869 Cycloalkyl alkanoic acids as integrin receptor antagonists
12/23/2004	US20040259843 Antidiabetic agents; hyperglycemic agents; obesity; atherosclerosis; immunomodulatory agents
12/23/2004	US20040259826 Mitotic kinesin inhibitors
12/23/2004	US20040259734 Izoxazoline derivative and herbicide
12/23/2004	DE10326186A1 Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung Bicyclic heterocycles, pharmaceutical compositions containing them, their use and process for their preparation
12/23/2004	DE10325962A1 Aroylsemicarbazidderivate Aroylsemicarbazidderivate
12/23/2004	DE10323701A1 Verfahren zur Synthese heterocyclischer Verbindungen Process for the synthesis of heterocyclic compounds
12/23/2004	DE10308355A1 Aryl-cycloalkyl substituierte Alkansäurederivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel Aryl-cycloalkyl substituted alkane acid derivatives, processes for their preparation and their use as medicaments
12/23/2004	DE10308354A1 Cycloalkylderivate mit biosteren Carbonsäure-Gruppen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Cycloalkyl biosteren with carboxylic acid groups, method for their preparation and their use as medicaments
12/23/2004	CA2528652A1 Nk1 antagonist
12/23/2004	CA2528644A1 Novel piperazinyl-aryloxy and piperazinyl-heteroaryloxy-n-aryl lactams
12/23/2004	CA2527851A1 Hepatitis c virus inhibitors
12/23/2004	CA2527037A1 2,3-substituted 5,6-diaryl-pyrazine derivatives as cb1 modulators
12/23/2004	CA2526387A1 Benzamide derivative or salt thereof
12/23/2004	CA2525207A1 Substituted piperidine carbamates for use as inhibitors of hormone sensitive lipase
12/22/2004	EP1487843A2 Substituted phenylacetic acids
12/22/2004	EP1487828A2 Morpholinyl-urea derivatives for use of the treatment of inflamatory diseases
12/22/2004	EP1487827A1 Anti-inflammatory morpholin-acetamide derivatives
12/22/2004	EP1487824A1 Diamino-pyrimidines and their use as angiogenesis inhibitors
12/22/2004	EP1487823A1 Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with cdk inhibitory activity
12/22/2004	EP1487813A1 Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders
12/22/2004	EP1487809A1 Process for the preparation of morpholine derivatives and intermediates therefore
12/22/2004	EP1487807A2 New compounds
12/22/2004	EP1487803A1 Indazoles substituted with an anti-cancerous activity
12/22/2004	EP1487801A1 7-arylsulfonamido-2,3,4,5-tetrahydro-1h-benzo[d]azepine derivatives with 5-ht6 receptor affinity for the treatment of cns disorders
12/22/2004	EP1487797A1 Hetero-bridge substituted 8-arylquinoline pde4 inhibitors
12/22/2004	EP1487794A1 Monocyclic aroylpyridinones as antiinflammatory agents
12/22/2004	EP1487793A1 Piperidine derivatives useful as modulators of chemokine receptor activity
12/22/2004	EP1487792A1 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators
12/22/2004	EP1487785A2 Novel florfenicol-type antibiotics
12/22/2004	EP1487455A1 Morpholine derivatives substituted at the 2-position by an arylalkylurea group for use as ccr-3 antagonists in the treatment of inflammatory conditions
12/22/2004	EP1487454A1 Morpholine derivatives substituted at the 2-position by a heterocyclylalkylurea group for use as ccr-3 antagonists in the treatment of inflammatory conditions
12/22/2004	EP1487441A2 Benzimidazoles and their use as mitogen-activated- and rho-kinase inhibitors
12/22/2004	EP1487435A1 Azetidine derivatives as ccr-3 receptor antagonists
12/22/2004	EP1406894B1 Piperazine oxime derivatives having nk-1 receptor antagonistic activity
12/22/2004	EP1373264B1 3-heterocyclylpropanohydroxamic acid as procollagen c-proteinase inhibitors
12/22/2004	EP1086076B1 Sulfonamide inhibitors of aspartyl protease
12/22/2004	EP0987254B1 Novel cyclic diamine compounds and medicine containing the same
12/22/2004	CN1556805A Piperidine derivative as NMDA receptor antagonist
12/22/2004	CN1556804A 3-substituted-4-pyrimidone derivatives
12/22/2004	CN1556803A New organic compounds for electroluminescence and oganic electroluminescent devices using the same
12/22/2004	CN1556797A Substituted isoxazole compound and its application as antibiotics
12/22/2004	CN1556702A Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
12/22/2004	CN1181059C Quinoline-4-base derivative I
12/21/2004	US6833453 As an example, manufacturing a 5-(tert-butylcarbamoyl)-amino-methyl-oxazolidinone by condensing a carbamate with a tert-butylcarbamoyl protected derivative of glycidylamine or a 3-amino-1-halopropanol
12/21/2004	US6833442 Complex and method for producing epoxides by using the complex
12/21/2004	US6833387 Chemical compounds
12/21/2004	US6833381 TNF-α inhibitors
12/21/2004	US6833378 Pyridines, pyrimidines, purinones, pyrrolopyrimidinones and pyrrolopyridinones; useful in the treatment disorders including CNS and stress-related disorders.
12/21/2004	US6833375 As inhibitors of the retinoic acid-metabolism, as drugs
12/16/2004	WO2004108719A1 2-[2-(4-morpholino)ethylamino]pyridine derivatives, method for preparing thereof and antiviral pharmaceutical composition comprising the same
12/16/2004	WO2004108718A1 Aroyl semicarbazide derivatives against thromboembolic diseases
12/16/2004	WO2004108694A1 N-alkynyl-2-heteroaryloxyalkylamides for use as fungicides
12/16/2004	WO2004108692A1 Sulphonamide compounds that modulate chemokine receptor activity (ccr4)
12/16/2004	WO2004108688A1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
12/16/2004	WO2004108686A2 Benzimidazole compounds having hypoglycemic activity
12/16/2004	WO2004108684A1 Novel azole derivative having antifungal activity
12/16/2004	WO2004108672A1 Isoindolin-1-one compounds as kinase inhibitors
12/16/2004	WO2004108664A2 Bicyclic heterocycles, drugs containing said compounds, the use thereof and method for preparing the same
12/16/2004	WO2004108133A2 Modulators of vr1 receptor
12/16/2004	WO2004108086A2 HYDANTOIN DERIVATIVES AS INHIBITORS OF TUMOR NECROSIS FACTOR-α CONVERTING ENZYME (TACE)
12/16/2004	WO2004108068A2 4-[4-(4-morpholino)anilino]pyrimidine derivatives, method for preparing thereof and antiviral pharmaceutical composition comprising the same
12/16/2004	WO2004096948A8 Electron transport agents for organic electronic devices
12/16/2004	WO2004089882A3 Aromatic sulfonamides as peroxynitrite-rearrangement catalysts
12/16/2004	WO2004085433A3 Positive allosteric modulators of the nicotinic acetylcholine receptor
12/16/2004	WO2004080411A3 Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto
12/16/2004	WO2003090539A8 3-heteroaryl substituted 5-methyloxymethyl isoxazolines used as herbicides
12/16/2004	WO2003063797A8 Cycloalkyl inhibitors of potassium channel function
12/16/2004	US20040254376 Cyclic amidine derivative
12/16/2004	US20040254373 Positive allosteric modulators of the nicotinic acetylcholine receptor
12/16/2004	US20040254249 Nonsteroidal antiinflammatory agents
12/16/2004	US20040254231 Antiinflammatory agents; alcoholism; antiallergens; chronic obstructive pulmonary disease; cardiovascular disorders; antiarthritic agents; autoimmune disease; chronic fatigue syndrome; multiple sclerosis
12/16/2004	US20040254220 Histone deacetylase inhibitors
12/16/2004	US20040254217 Aniline derivatives, their manufacture and use as pharmaceutical agents
12/16/2004	US20040254184 Psychological disorders; antidepressants; anxiolytic agents; analgesics; antiinflammatory agents; central nervous system disorders
12/16/2004	US20040254182 Enhanced propertied pharmaceuticals
12/16/2004	US20040254180 Isoxazolidine compounds useful in the treatment of diabetes, hyperlipidemia, and atherosclerosis in mammals
12/16/2004	US20040254177 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
12/16/2004	US20040254166 Substituted phenyl acetamides and their use as protease inhibitors
12/16/2004	US20040254162 Oxazolidinone derivatives as antimicrobials
12/16/2004	US20040254159 Antiproliferative agents
12/16/2004	DE10322469A1 Heterocyclische Verbindungen Heterocyclic Compounds
12/16/2004	CA2528924A1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
12/16/2004	CA2528233A1 Aroylsemicarbazide derivatives against thromboembolic diseases
12/16/2004	CA2527814A1 Isoindolin-1-one compounds as kinase inhibitors
12/16/2004	CA2526995A1 Bicyclic heterocycles, drugs containing said compounds, the use thereof and method for preparing the same
12/16/2004	CA2525093A1 N-alkynyl-2-heteroaryloxyalkylamides for use as fungicides
12/15/2004	EP1486549A1 Organic electroluminescent element
12/15/2004	EP1486494A1 N-substituted benzothiophenesulfonamide derivative
12/15/2004	EP1486490A1 Azole compounds
12/15/2004	EP1486486A2 Substituted B-thiocarboxylic acids
12/15/2004	EP1486207A2 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same
12/15/2004	EP1485387A1 Carbamates as hiv protease inhibitors
12/15/2004	EP1485381A1 Azolylaminoazine as inhibitors of protein kinases
12/15/2004	EP1485380A1 Azolylaminoazines as inhibitors of protein kinases
12/15/2004	EP1485379A1 Beta 3-adrenergic receptor agonists

1 ... 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 ... 647